Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 58 min ago
Peer-reviewedCC BYCardiology research

Personalized Prevention of Cardiovascular Diseases Through Measurement of Plaque Burden in the Carotid Artery

  • Ansgar Adams1
  • Michel Romanens2
  1. 1BG Prevent GmbH Health Centre Koblenz, Koblenz, Germany
  2. 2Vascular Risk Foundation (Varifo), Olten, Switzerland
Read full textPDFDOICite

Abstract

Background: This study provides an overview of the results of carotid screening for the prevention of cardiovascular disease.

Methods: Between 2009 and 2026, 11,540 individuals, 45% of whom were women, aged 20–65 years without clinical signs of cardiovascular disease, underwent carotid ultrasound examinations. Over 8,800 follow-up examinations were also performed. The total plaque area (TPA) and maximum plaque thickness were measured.

Results: TPA was presented as percentile curves according to age and sex. In a second cohort, age-related TPA thresholds for coronary stenosis ≥ 50% were determined. Advanced atherosclerosis (type III/IVb) is associated with a high risk of cardiovascular disease. Early treatment with statins improves the prognosis of these patients. The individual course of the disease with rapid progression of plaque burden could not be predicted based on classic risk factors. Of 75 patients with advanced atherosclerosis who suffered a myocardial infarction or ischemic stroke, 35% had a low PROCAM risk (< 10%) and only 27% had a high PROCAM risk. Mortality (from any cause) was significantly lower in men treated with statins.

Conclusions: Measuring plaque burden in the carotid artery allows for a good estimation of an individual’s risk of a cardiovascular event. In this non-randomized observational study, statin treatment significantly improved the prognosis in subjects with advanced carotid artery atherosclerosis (type III-IVb findings on ultrasound).

Related

  1. Editorial: Cancer and cardiovascular diseases: common mechanisms and strategies of prevention
    Paola Patrignani, Pietro Minuz, Dieter Steinhilber
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossref
  2. Delivery of cardiac rehabilitation through hybrid models and alternative settings by country income classification and decade: Comparisons from the International Council of Cardiovascular Prevention and Rehabilitation’s 2025 Global Audit Update
    Gabriela L. M. Ghisi, Rachael P. Carson, Karam Turk Adawi +21
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthInfectious diseasePLOS
  3. DRFAS-enhanced personalized federated learning for secure and robust cardiovascular disease detection
    V. Karthik, OmKumar ChandraUmakantham, Sudhakaran Gajendran +1
    Scientific ReportsPeer-reviewedCC BYFull textGeneral medicineDOAJ
  4. How can healthy ageing programs be conceptualized within the framework of personalized prevention?
    S Boccia, S Farina, E Giacobini +1
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMCEurope PMC
  5. Application of Artificial Intelligence for Predicting Sports Injuries and Customizing Personalized Prevention Strategies: A Scoping Review
    Wissem Dhahbi, Nidhal Jebabli, Marouen Souaifi +5
    BioengineeringPeer-reviewedCC BYFull text27 citedSurgery & anaesthesiaOpenAlex

Cite

BibTeXRIS
BibTeX
@article{adams2026personalized,
  title = {{Personalized Prevention of Cardiovascular Diseases Through Measurement of Plaque Burden in the Carotid Artery}},
  author = {Ansgar Adams and Michel Romanens},
  journal = {Cardiology research},
  year = {2026},
  month = oct,
  doi = {10.14740/cr2325},
  url = {https://europepmc.org/article/PMC/PMC13719636},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Personalized Prevention of Cardiovascular Diseases Through Measurement of Plaque Burden in the Carotid Artery
AU  - Ansgar Adams
AU  - Michel Romanens
PY  - 2026
DA  - 2026/10/22
JO  - Cardiology research
DO  - 10.14740/cr2325
UR  - https://europepmc.org/article/PMC/PMC13719636
AB  - Background: This study provides an overview of the results of carotid screening for the prevention of cardiovascular disease.  Methods: Between 2009 and 2026, 11,540 individuals, 45% of whom were women, aged 20–65 years without clinical signs of cardiovascular disease, underwent carotid ultrasound examinations. Over 8,800 follow-up examinations were also performed. The total plaque area (TPA) and maximum plaque thickness were measured.  Results: TPA was presented as percentile curves according to age and sex. In a second cohort, age-related TPA thresholds for coronary stenosis ≥ 50% were determined. Advanced atherosclerosis (type III/IVb) is associated with a high risk of cardiovascular disease. Early treatment with statins improves the prognosis of these patients. The individual course of the disease with rapid progression of plaque burden could not be predicted based on classic risk factors. Of 75 patients with advanced atherosclerosis who suffered a myocardial infarction or ischemic stroke, 35% had a low PROCAM risk (< 10%) and only 27% had a high PROCAM risk. Mortality (from any cause) was significantly lower in men treated with statins.  Conclusions: Measuring plaque burden in the carotid artery allows for a good estimation of an individual’s risk of a cardiovascular event. In this non-randomized observational study, statin treatment significantly improved the prognosis in subjects with advanced carotid artery atherosclerosis (type III-IVb findings on ultrasound).
SN  - 1923-2829
SN  - 1923-2837
ER  -